Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors

被引:39
作者
El Lakis, Mustapha [1 ]
Gianakou, Andreas [1 ]
Nockel, Pavel [1 ]
Wiseman, Douglas [1 ]
Tirosh, Amit [1 ,2 ]
Quezado, Martha A. [3 ]
Patel, Dhaval [1 ]
Nilubol, Naris [1 ]
Pacak, Karel [4 ]
Sadowski, Samira M. [5 ]
Kebebew, Electron [6 ]
机构
[1] NCI, Endocrine Oncol Branch, Bethesda, MD 20892 USA
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] NCI, Pathol Lab, Bldg 10, Bethesda, MD 20892 USA
[4] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA
[5] Univ Hosp Geneva, Dept Thorac & Endocrine Surg, Geneva, Switzerland
[6] Stanford Univ, Dept Surg, 300 Pasteur Dr,H3642, Stanford, CA 94305 USA
关键词
GA-68-DOTATATE; MANAGEMENT; PET/CT;
D O I
10.1001/jamasurg.2018.3475
中图分类号
R61 [外科手术学];
学科分类号
摘要
IMPORTANCE Neuroendocrine tumors (NETs) express somatostatin receptors, which can be targeted with radiolabeled peptides. In a variety of solid tumors, radioguided surgery (RGS) has been used to guide surgical resection. Gallium 68 (Ga-68) dota peptides have been shown to be more accurate than other radioisotopes for detecting NETs. A pilot study previously demonstrated the feasibility and safety of Ga-68-dotatate RGS for patients with NETs. OBJECTIVE To evaluate what intraoperative techniques and thresholds define positive lesions that warrant resection during Ga-68-dotatate RGS. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study, conducted between October 23, 2013, and February 14, 2018, included 44 patients with NETs who underwent Ga-68-dotatate RGS. INTERVENTION Gallium 68-dotatate RGS. MAIN OUTCOMES AND MEASURES The in vivo and ex vivo tumor to background ratio (TBR) was assessed for resected lesions and correlated with the histopathologic findings. RESULTS Forty-four patients (22 women and 22 men; mean [SD] age, 51.0 [13.7] years) had 133 lesions detected on preoperative imaging scans, with a diagnosis of a pancreatic NET (19 of 44 [43%]), gastrointestinal NET (22 of 44 [50%]), and pheochromocytoma or paraganglioma (3 of 44 [7%]). The TBR was obtained by normalizing to the omentum (106 of 133 [79.7%]) or other solid organs (27 of 133 [20.3%]). The omentum had a significantly lower mean (SD) count than other solid organs for background count activity 3 hours after injection (22.1 [17.0] vs 34.5 [39.0]; P <.001). The lesions containing NETs had a higher TBR than those that did not contain NETs (18.9 vs 4.4; P <.001). On a receiver operating characteristic curve analysis, a TBR of 2.5 had a sensitivity of 90% and a specificity of 25%, and a TBR of 16 had a sensitivity of 54% and a specificity of 81%. CONCLUSIONS AND RELEVANCE A TBR of 2.5 or greater is a highly sensitive threshold for indicating a lesion to be consistent with a NET on histologic findings and thus warranting surgical resection. The omentum should be used as the background count activity for Ga-68-dotatate RGS for patients with abdominal NETs.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 16 条
[1]  
Cuccurullo V, 2017, NUCL MED REV, V20, P49, DOI 10.5603/NMR.2017.0003
[2]   Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions [J].
Deroose, Christophe M. ;
Hindie, Elif ;
Kebebew, Electron ;
Goichot, Bernard ;
Pacak, Karel ;
Taieb, David ;
Imperiale, Alessio .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (12) :1949-1956
[3]   Minimally invasive radioguided parathyroid surgery: A literature review [J].
Desiato, Vincenzo ;
Melis, Marcovalerio ;
Amato, Bruno ;
Bianco, Tommaso ;
Rocca, Aldo ;
Amato, Maurizio ;
Quarto, Gennaro ;
Benassai, Giacomo .
INTERNATIONAL JOURNAL OF SURGERY, 2016, 28 :S84-S93
[4]   Response after Surgical Resection of Metastatic Pheochromocytoma and Paraganglioma: Can Postoperative Biochemical Remission Be Predicted? [J].
Ellis, Ryan J. ;
Patel, Dhaval ;
Prodanov, Tamara ;
Sadowski, Samira ;
Nilubol, Naris ;
Adams, Karen ;
Steinberg, Seth M. ;
Pacak, Karel ;
Kebebew, Electron .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) :489-496
[5]   ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors [J].
Falconi, Massimo ;
Bartsch, Detlef Klaus ;
Eriksson, Barbro ;
Kloeppel, Guenter ;
Lopes, Jose M. ;
O'Connor, Juan M. ;
Salazar, Ramon ;
Taal, Babs G. ;
Vullierme, Marie Pierre ;
O'Toole, Dermot .
NEUROENDOCRINOLOGY, 2012, 95 (02) :120-134
[6]   Radio-guided surgery in neuroendocrine tumors [J].
Gulec, Seza A. ;
Baum, Richard .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (04) :309-315
[7]   Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors [J].
Haug, Alexander R. ;
Rominger, Axel ;
Mustafa, Mona ;
Auernhammer, Christoph ;
Goeke, Burkhard ;
Schmidt, Gerwin P. ;
Waengler, Bjoern ;
Cumming, Paul ;
Bartenstein, Peter ;
Hacker, Marcus .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (11) :1679-1683
[8]   High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours [J].
Hofman, Michael S. ;
Kong, Grace ;
Neels, Oliver C. ;
Eu, Peter ;
Hong, Emily ;
Hicks, Rodney J. .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2012, 56 (01) :40-47
[9]   Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology [J].
Intra, Mattia ;
de Cicco, Concetta ;
Gentilini, Oreste ;
Luini, Alberto ;
Paganelli, Giovanni .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (06) :957-958
[10]   Survival and prognostic factors in patients with small bowel carcinoid tumour [J].
Landerholm, K. ;
Zar, N. ;
Andersson, R. E. ;
Falkmer, S. E. ;
Jarhult, J. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (11) :1617-1624